Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea

Novo Nordisk · Phase 3 · Completed · Enrollment 359

NCT01557166

ArmPopulationDoseWeeksEstimandWeight change
Liraglutide 3.0 mgObesity or overweight3.0 mg32n/rn/r
PlaceboObesity or overweightn/r32n/rn/r